AJR Am J Roentgenol

1. XIANG JY, Zheng JY, Xie WH, Shi RY, et al
   Persistence of Microvascular Obstruction From Early to Late Gadolinium Enhancement Images on Cardiac MRI: Prognostic Utility After STEMI-Analysis of EARLY-MYO-CMR Registry Data.
   AJR Am J Roentgenol. 2025 Oct 1. doi: 10.2214/AJR.25.33747.
   

   >> Share

   
   

   
   Am Heart J

2. DILETTI R, Daemen J, Faurie B, Barbierato M, et al
   Intravascular Ultrasound Guidance for Complex High-Risk Indicated Procedures: the IVUS CHIP Trial study design.
   Am Heart J. 2026 Jan 3:107339. doi: 10.1016/j.ahj.2026.107339.
   

   >> Share

   
   
3. TAMARAPPOO B, Wolny R, Tomasino GF, Berman D, et al
   Design and Rationale of the WARRIOR Ancillary Study for Coronary CT Angiographic Analysis.
   Am Heart J. 2026 Jan 2:107340. doi: 10.1016/j.ahj.2026.107340.
   

   >> Share

   
   
4. BORGES DO NASCIMENTO IJ, Lopes RD, Malveira De Lima MV, Itaborahy MF, et al
   Coevolutionary analysis of evidence and recommendations in STEMI clinical practice guidelines: A 33-year meta-research study of ACC, AHA, and ESC.
   Am Heart J. 2026;294:107326.
   

   >> Share

   
   
5. BOLLI R, Tang XL, Hare JM, Mitrani RD, et al
   Design and rationale of CATO, a Phase IIA, randomized, double-blind, placebo-controlled study of single or repeated intravenous administration of umbilical cord-derived mesenchymal stromal cells in ischemic cardiomyopathy.
   Am Heart J. 2026;294:107328.
   

   >> Share

   
   

   
   Am J Cardiol

6. OLIVERI F, van Oort MH, Phagu A, Bingen BO, et al
   Coronary Artery Compliance Modification after Non-Compliant Balloon Angioplasty and Intravascular Lithotripsy.
   Am J Cardiol. 2026 Feb 5:S0002-9149(26)00034.
   

   >> Share

   
   
7. SEIRAFI T, Zolotarova T, Levett JY, Angheluta AD, et al
   FFR-Guided Complete versus Culprit-Only Revascularization in Patients with Myocardial Infarction: A Systematic Review and Meta-Analysis.
   Am J Cardiol. 2026 Feb 11:S0002-9149(26)00058.
   

   >> Share

   
   
8. STREPKOS D, Alexandrou M, Mutlu D, Carvalho PEP, et al
   Death Following Percutaneous Coronary Intervention: Data from the PROGRESS-COMPLICATIONS registry.
   Am J Cardiol. 2026 Feb 13:S0002-9149(26)00067.
   

   >> Share

   
   
9. KUMAR S, Thotakura S, Ng P, Kearney KE, et al
   Outcomes of Same-Day Discharge in Chronic Total Occlusion Percutaneous Coronary Intervention.
   Am J Cardiol. 2026 Feb 12:S0002-9149(26)00064.
   

   >> Share

   
   
10. PRAVDA NS, Itelman E, Plakht Y, Schifter L, et al
    Cardiovascular Magnetic Resonance-based Tissue Characteristics and Clinical Outcomes in Apical Hypertrophic Cardiomyopathy.
    Am J Cardiol. 2026 Feb 10:S0002-9149(26)00062.
    

    >> Share

    
    
11. DAWOUD A, Kamel-Abusalha L, Taylor M, Qwaider M, et al
    Colchicine and Clinical Outcomes in Patients With Coronary Artery Disease and Elevated C-Reactive Protein: A Real-World Propensity-Matched Study.
    Am J Cardiol. 2026 Feb 9:S0002-9149(26)00046.
    

    >> Share

    
    
12. MEDINA-INOJOSA JR, Sachdeva R
    Colchicine's Unfinished Story in Cardiovascular Care.
    Am J Cardiol. 2026 Feb 8:S0002-9149(26)00047.
    

    >> Share

    
    

    
    Angiology

13. OYAMA Y, Ueki Y, Otagiri K, Itagaki T, et al
    Association Between Achilles Tendon Thickness as Assessed by Ultrasound and Coronary Artery Disease Severity in Patients Undergoing Percutaneous Coronary Intervention.
    Angiology. 2026 Feb 14:33197261418308. doi: 10.1177/00033197261418308.
    

    >> Share

    
    

    
    Ann Clin Biochem

14. JIALAL I, Devaraj S
    Cardiovascular-Kidney-Metabolic (CKM) Syndrome and the Clinical Laboratory.
    Ann Clin Biochem. 2026 Feb 10:45632261420660. doi: 10.1177/00045632261420660.
    

    >> Share

    
    

    
    Ann Intern Med

15. 
    Correction: Chronic Coronary Artery Disease.
    Ann Intern Med. 2026 Feb 10. doi: 10.7326/ANNALS-26-00353.
    

    >> Share

    
    

    
    Ann Thorac Surg

16. TAM DY, Sallam A, Elsherbini A, Chen Q, et al
    Conduit choice and volume-outcome relationships in multi-arterial coronary artery bypass grafting among Medicare beneficiaries in the US.
    Ann Thorac Surg. 2026 Feb 13:S0003-4975(26)00124.
    

    >> Share

    
    
17. KAWAMOTO N, Yamashita K, Suzuki K, Kakuta T, et al
    Robotic mitral valve repair and simultaneous on-pump coronary artery bypass grafting to the left anterior descending artery.
    Ann Thorac Surg. 2026 Feb 12:S0003-4975(26)00119.
    

    >> Share

    
    

    
    Cardiovasc Res

18. GUO Z, Li L, Luo J, Xue W, et al
    The Ets2 super-enhancer modulates endothelial-mesenchymal transition during cardiac ageing.
    Cardiovasc Res. 2026;121:2892-2908.
    

    >> Share

    
    
19. LI W, Zhou S, Liu J, Luo L, et al
    Identification of ALDH1A2-mediated cardioprotective benefits in myocardial ischaemia-reperfusion injury.
    Cardiovasc Res. 2026;121:2922-2938.
    

    >> Share

    
    

    
    Catheter Cardiovasc Interv

20. SAMIMI S, Chaaya RGB, Kharsa C, Hatab T, et al
    Very Young Adults With Myocardial Infarction Undergoing PCI: Insights From the Houston Methodist Young-MI PCI Registry.
    Catheter Cardiovasc Interv. 2026 Feb 12. doi: 10.1002/ccd.70490.
    

    >> Share

    
    
21. KARAKURT H, Karakurt ST
    The Prognostic Significance of the Novel Global Immune-Nutrition-Inflammation Index in Forecasting In-Hospital Mortality in Patients With ST-Elevation Myocardial Infarction.
    Catheter Cardiovasc Interv. 2026 Feb 11. doi: 10.1002/ccd.70519.
    

    >> Share

    
    
22. FERNANDEZ J, Khan N, Rubens M, Majdpour D, et al
    Incidence and In-Hospital Mortality of Ventricular Septal Rupture Following Acute Myocardial Infarction.
    Catheter Cardiovasc Interv. 2026 Feb 8. doi: 10.1002/ccd.70508.
    

    >> Share

    
    
23. SHARMA P, Bose A, Nema R, Barwad P, et al
    Coronary Artery Perforation During Percutaneous Coronary Intervention in a Myocardial Bridge: Case Report and Management Considerations.
    Catheter Cardiovasc Interv. 2025 Dec 10. doi: 10.1002/ccd.70429.
    

    >> Share

    
    
24. ADHYAPAK SM, Menon PG, George S, Varghese K, et al
    Impact of Individual Culprit Coronary Arteries Revascularized by Primary PCI on Clinical Outcomes.
    Catheter Cardiovasc Interv. 2026;107:842-844.
    

    >> Share

    
    
25. AARTS HM, Hemelrijk KI, Broeze GM, Muller SA, et al
    Nationwide Analysis of PCI After TAVR From the Netherlands Heart Registration.
    Catheter Cardiovasc Interv. 2026;107:824-832.
    

    >> Share

    
    
26. AWASHRA A, AbuBaha M, Emara A, Hamdan A, et al
    Reassessing PCI Timing in High Bleeding Risk Patients: Evidence, Strategies, and Outcomes.
    Catheter Cardiovasc Interv. 2026;107:780-794.
    

    >> Share

    
    
27. MA S, Chen Z, He Y, Zhou M, et al
    Stent-Free PCI With OCT-Guided Drug-Coated Balloon Angioplasty for Calcified Coronary Stenosis After Kawasaki Disease.
    Catheter Cardiovasc Interv. 2026;107:853-857.
    

    >> Share

    
    
28. CAO B, Lin S, Chen X
    Unveiling Hidden Threats: Intravascular Ultrasound-Guided Precise Intervention for Coronary Ostium Obstruction Risk in Bicuspid Transcatheter Aortic Valve Replacement.
    Catheter Cardiovasc Interv. 2025 Dec 8. doi: 10.1002/ccd.70431.
    

    >> Share

    
    
29. MISHRA K, Hamedi K, Secaira RA, Lau TK, et al
    A Novel "Telescopic Locking" Technique for Precise Stent Placement in the Ostium of the Left Anterior Descending Artery.
    Catheter Cardiovasc Interv. 2026;107:713-716.
    

    >> Share

    
    
30. XIONG Q, Chen S, Zhang W, Xie Y, et al
    Anomalous Intercoronary Communication in the Setting of Chronic Left Circumflex Occlusion.
    Catheter Cardiovasc Interv. 2026;107:740-745.
    

    >> Share

    
    
31. FANG Z, Xue X, Yan S, Zhu J, et al
    The "Fracture-Advance" Technique in Intravascular Lithotripsy for the Treatment of Severe and Tortuous Calcified Coronary Lesions.
    Catheter Cardiovasc Interv. 2026;107:736-739.
    

    >> Share

    
    
32. PEREIRA AMB, Rosa AA, Flavio-Reis VHP, Pessoa-Goncalves YM, et al
    Outcomes and Risk Profiles of Acute Coronary Syndrome Patients Treated With Percutaneous Coronary Intervention: Insights From a Brazilian Tertiary Care Center.
    Catheter Cardiovasc Interv. 2025 Dec 3. doi: 10.1002/ccd.70401.
    

    >> Share

    
    

    
    Circ Cardiovasc Imaging

33. ZHANG J, Meng W, Qin C
    Rare Cause of Mitral Prolapse: Myocardial Infarction With Nonobstructive Coronary Arteries.
    Circ Cardiovasc Imaging. 2026 Feb 12:e019488.
    

    >> Share

    
    

    
    Circ Genom Precis Med

34. SCHMIDT LE, Burnap SA, Singh B, Takov K, et al
    Integrative Proteomic and Lipidomic Analysis of Post-Myocardial Infarction Patients Treated With PCSK9 Antibodies and Statins.
    Circ Genom Precis Med. 2026 Feb 10:e005345. doi: 10.1161/CIRCGEN.125.005345.
    

    >> Share

    
    
35. SELBER-HNATIW S, Trajanoska K, Pelletier J, Su CY, et al
    Phenome-Wide Mendelian Randomization Identifying Circulating Proteins for Cardiovascular Traits in Populations of African Ancestry.
    Circ Genom Precis Med. 2026 Feb 9:e005159. doi: 10.1161/CIRCGEN.125.005159.
    

    >> Share

    
    

    
    Circ Res

36. WU X, Liu L, Huang Y, Ling Y, et al
    Grhl3 Downregulation Facilitates ECM Adaptation for Fibroblast to iCM Commitment.
    Circ Res. 2026;138:e327726.
    

    >> Share

    
    

    
    Circulation

37. LI N, Hao Z, Yang H, Cai J, et al
    CCR8 Expression on Regulatory T Cells Reveals Trajectories of Tissue Adaptation and Protects Against Myocardial Infarction-Induced Tissue Damage.
    Circulation. 2026 Feb 13. doi: 10.1161/CIRCULATIONAHA.125.076426.
    

    >> Share

    
    
38. BAI X, Ren R, Yuan J, Yu L, et al
    Macrophage PRMT9 Ameliorates Acute Myocardial Infarction by Promoting Symmetric Dimethylation and Degradation of STAT1.
    Circulation. 2026 Feb 11. doi: 10.1161/CIRCULATIONAHA.125.076101.
    

    >> Share

    
    
39. MADHAVAN MV, Gregson J, Redfors B, Chen S, et al
    Spontaneous Myocardial Infarction After Left Main Revascularization: The EXCEL Trial.
    Circulation. 2026 Feb 10. doi: 10.1161/CIRCULATIONAHA.125.075875.
    

    >> Share

    
    
40. ZHAO L, Zhao C, Wang Y
    Letter by Zhao et al Regarding Article, "Causal Relevance of Lp(a) for Coronary Heart Disease and Stroke Types in East Asian and European Ancestry Populations: A Mendelian Randomization Study".
    Circulation. 2026;153:e71-e72.
    

    >> Share

    
    
41. HUANG Q, Jian X, Wu F
    Letter by Huang et al Regarding Article, "Causal Relevance of Lp(a) for Coronary Heart Disease and Stroke Types in East Asian and European Ancestry Populations: A Mendelian Randomization Study".
    Circulation. 2026;153:e69-e70.
    

    >> Share

    
    
42. WU Y, Nguyen T, Wang Y, Zhou Y, et al
    Cardiomyocyte-Specific modRNA-Induced FoxM1 Overexpression Promotes Recovery From Myocardial Infarction in Adult Mammals.
    Circulation. 2026;153:463-466.
    

    >> Share

    
    
43. DARDARI ZA, Yao Z, Zhang J, Bakoyannis G, et al
    Prospective Associations of Obesity and Obesity Severity With 9 Cardiovascular Outcomes: The Cross-Cohort Collaboration.
    Circulation. 2026 Feb 12. doi: 10.1161/CIRCULATIONAHA.125.075327.
    

    >> Share

    
    
44. KHAN SS, Greenland P, Hayman LL, Khera R, et al
    Criteria to Assess the Predictive and Clinical Utility of Novel Models, Biomarkers, and Tools for Risk of Cardiovascular Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2026 Feb 11. doi: 10.1161/CIR.0000000000001401.
    

    >> Share

    
    
45. RHEE JW, Bolton KL, Gupta D, Weeks LD, et al
    Clonal Hematopoiesis and Its Cardiovascular Implications: A Scientific Statement From the American Heart Association.
    Circulation. 2026 Feb 10. doi: 10.1161/CIR.0000000000001404.
    

    >> Share

    
    
46. VON HUNDELSHAUSEN P, Siess W, Duan R, Bohnert T, et al
    Involvement of Btk in Cardiovascular Disease and Its Therapeutic Targeting.
    Circulation. 2026;153:435-456.
    

    >> Share

    
    
47. ZHANG L, Iliescu C, Ferencik M, Finamore V, et al
    Coronary Atherosclerosis in Patients With Cancer and Survivors: A Scientific Statement From the American Heart Association.
    Circulation. 2026 Feb 9. doi: 10.1161/CIR.0000000000001391.
    

    >> Share

    
    

    
    Eur Heart J

48. ISHII M, Nakamura T, Ikebe S, Otsuka Y, et al
    Air pollution before and during the COVID-19 pandemic: changes in risk of acute myocardial infarction.
    Eur Heart J. 2026 Feb 13:ehag102. doi: 10.1093.
    

    >> Share

    
    
49. JUNG M, Schmidt A, Sansonetti M, Al Soodi B, et al
    Macrophage-specific circular RNA circHIPK2, inflammation, and fibrosis after myocardial infarction.
    Eur Heart J. 2026 Feb 11:ehaf1116. doi: 10.1093/eurheartj/ehaf1116.
    

    >> Share

    
    
50. SERRUYS PW, Oshima A, Ferraz-Costa G, Garg S, et al
    Coronary revascularization: a long-term perspective.
    Eur Heart J. 2025 Nov 22:ehaf883. doi: 10.1093.
    

    >> Share

    
    
51. LEE SJ, Lee SJ, Hong SJ, Cho DK, et al
    Optical coherence tomography-guided stent optimization for complex coronary lesions: the OCCUPI trial.
    Eur Heart J. 2026;47:608-621.
    

    >> Share

    
    
52. MINER S, Mejia-Renteria H, Leone AM, Velollari O, et al
    Endotypes of angina with non-obstructive coronary arteries: a prospective multicentre study.
    Eur Heart J. 2026;47:594-604.
    

    >> Share

    
    
53. DILLINGER JG, Pezel T, Batias L, Angoulvant D, et al
    Aspirin dosing after acute coronary syndrome with suspected aspirin resistance: the ANDAMAN trial.
    Eur Heart J. 2025 Aug 30:ehaf680. doi: 10.1093.
    

    >> Share

    
    

    
    Heart

54. GENG Y, Guan C, Jiang Y, Yang W, et al
    Prognostic impact of guideline-directed medical therapy after functionally complete revascularisation in patients with obstructive coronary artery diseases.
    Heart. 2025 Aug 7:heartjnl-2025-325670. doi: 10.1136/heartjnl-2025-325670.
    

    >> Share

    
    

    
    J Am Coll Cardiol

55. VELASQUEZ DE, Joynt Maddox KE, Messac L
    Financial Assistance Policies to Improve Post-Myocardial Infarction Care.
    J Am Coll Cardiol. 2026 Feb 2:S0735-1097(25)10586.
    

    >> Share

    
    
56. MARK DB, Rao SV
    Choosing Between CABG and PCI for 3-Vessel Coronary Disease: What's Cost Got to Do With It?
    J Am Coll Cardiol. 2026 Feb 2:S0735-1097(25)10573.
    

    >> Share

    
    
57. WU Z, Liu B, Wang X, Alessa H, et al
    Effect of Low-Carbohydrate and Low-Fat Diets on Metabolomic Indices and Coronary Heart Disease in U.S. Individuals.
    J Am Coll Cardiol. 2026 Jan 30:S0735-1097(25)10569.
    

    >> Share

    
    
58. SAADAT S, Engoren M, Habib RH, Lorusso R, et al
    Coronary Artery Bypass Grafting After Acute Myocardial Infarction With Cardiogenic Shock: Analysis of the Society of Thoracic Surgeons Adult Cardiac Surgery Database.
    J Am Coll Cardiol. 2026 Feb 3:S0735-1097(25)10567.
    

    >> Share

    
    
59. ELKARYONI A, Gordon PC, Orui H, Saad M, et al
    Immediate Coronary Angiography for STEMI and Out-of-Hospital Cardiac Arrest: Hospital Variation in the NCDR Registry.
    J Am Coll Cardiol. 2026 Jan 30:S0735-1097(25)10596.
    

    >> Share

    
    
60. ARMILLOTTA M, Bergamaschi L, Angeli F, Fedele D, et al
    Rethinking Cardiovascular Risk Across the Universal Definition: A Call to Reconsider Prognosis and Care.
    J Am Coll Cardiol. 2026 Feb 2:S0735-1097(25)10587.
    

    >> Share

    
    
61. LUO Y
    Cardiovascular Endpoint Adjudication in Clinical Trials: A Proactive and Collaborative AI Approach.
    J Am Coll Cardiol. 2026 Feb 2:S0735-1097(25)10571.
    

    >> Share

    
    
62. BIKDELI B, Cohen DJ, Stone GW
    Extension Reports: The Neglected Sequel of Cardiovascular Trials.
    J Am Coll Cardiol. 2026 Jan 30:S0735-1097(25)10562.
    

    >> Share

    
    
63. JACOBS AE, Kapologwe NA, Schwartz JI
    Supply Chains as Health Infrastructure: Evidence-Based Approaches to Improving Cardiovascular Medication Access in Africa.
    J Am Coll Cardiol. 2026 Feb 2:S0735-1097(25)10561.
    

    >> Share

    
    
64. GAO R, Song L, Fu G, Guan C, et al
    Sirolimus-Eluting Iron Bioresorbable Scaffolds vs Everolimus-Eluting Stents for Percutaneous Coronary Intervention: A Randomized Trial (IRONMAN II).
    J Am Coll Cardiol. 2026 Feb 11:S0735-1097(25)10492.
    

    >> Share

    
    
65. TONG G, Li F
    Reconstructing Pseudo Individual Patient-Level Data From Published Survival Curves in Cardiovascular Trials.
    J Am Coll Cardiol. 2026;87:530-532.
    

    >> Share

    
    
66. AIMO A, Butler J, De Michieli L, Mendieta G, et al
    Biomarkers for Cardiovascular Drug Development: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2026 Feb 3:S0735-1097(25)10606.
    

    >> Share

    
    

    
    J Cardiovasc Pharmacol

67. KIM HL, Lee B, Im S
    The comparative effects of S-amlodipine versus racemic amlodipine on long-term cardiovascular outcomes in subjects with hypertension: a nationwide population-based cohort study.
    J Cardiovasc Pharmacol. 2026 Feb 9. doi: 10.1097/FJC.0000000000001793.
    

    >> Share

    
    

    
    J Electrocardiol

68. YANG M, Zhao H, Yin Y, Li X, et al
    Predictive value of standard electrocardiographic parameters for major adverse cardiovascular events in patients with coronary heart disease: A retrospective cohort study.
    J Electrocardiol. 2026;95:154200.
    

    >> Share

    
    
69. MOHAN C, Gururani K, Rawat A, Singh Y, et al
    Diagnostic agreement of smartphone-based electrocardiogram with coronary angiography in identifying vessel involvement in patients with myocardial infarction.
    J Electrocardiol. 2026;95:154210.
    

    >> Share

    
    

    
    J Mol Cell Cardiol

70. ZHOU MM, Xu L, Huang DZ, Wang X, et al
    KCNQ2 downregulation in left stellate ganglion neurons exacerbates malignant ventricular arrhythmias after myocardial infarction.
    J Mol Cell Cardiol. 2026;213:59-73.
    

    >> Share

    
    
71. DONG K, Zuo Y, Yao Y, He X, et al
    Coronary artery disease risk gene PRDM16 regulates smooth muscle homeostasis.
    J Mol Cell Cardiol. 2026;213:74-83.
    

    >> Share

    
    

    
    J Thorac Cardiovasc Surg

72. SILVA CAMPOS AA, da Silveira Maia A, Vilca Mejia OA
    Redefining Non-Inferiority in Multivessel Coronary Disease and the Enduring Value of Coronary Artery Bypass Grafting.
    J Thorac Cardiovasc Surg. 2026 Feb 7:S0022-5223(26)00096.
    

    >> Share

    
    

    
    JAMA

73. XU C, Qu JZ, Wang D
    Determining Duration of Oral Anticoagulation Treatment for New-Onset AF After Coronary Artery Bypass Grafting.
    JAMA. 2026 Feb 9. doi: 10.1001/jama.2025.25368.
    

    >> Share

    
    
74. HERRMANN FEM, Jeppsson A, Hagl C
    Determining Duration of Oral Anticoagulation Treatment for New-Onset AF After Coronary Artery Bypass Grafting -Reply.
    JAMA. 2026 Feb 9. doi: 10.1001/jama.2025.25371.
    

    >> Share

    
    

    
    Lancet

75. XIONG Y, Alemseged F, Cao Z, Schwamm LH, et al
    Tenecteplase versus standard medical treatment for basilar artery occlusion within 24 h (TRACE-5): a multicentre, prospective, randomised, open-label, blinded-endpoint, superiority, phase 3 trial.
    Lancet. 2026 Feb 5:S0140-6736(25)02633-9. doi: 10.1016/S0140-6736(25)02633.
    

    >> Share

    
    
76. TSIVGOULIS G, Palaiodimou L, Turc G
    Intravenous tenecteplase for acute ischaemic stroke within 24 h due to basilar artery occlusion.
    Lancet. 2026 Feb 5:S0140-6736(26)00139-X. doi: 10.1016/S0140-6736(26)00139.
    

    >> Share

    
    

    
    Mayo Clin Proc

77. SUMIDA K, Kovesdy CP
    Emerging Cardiovascular Risk Factors in Chronic Kidney Disease in the "Omics" Era: Gut and Beyond.
    Mayo Clin Proc. 2026 Feb 13:S0025-6196(25)07627.
    

    >> Share

    
    

    
    Mol Cell Biochem

78. ZHU M, Yin F, Qiu Y, Liu Y, et al
    Mechanism of maternal gestational diabetes mellitus exacerbating myocardial injury in male offspring by upregulating growth differentiation factor 15 to promote mitochondrial dysfunction.
    Mol Cell Biochem. 2026;481:339-353.
    

    >> Share

    
    
79. NAYAK SPRR, Pohokar P, Arasu MV, Soundharrajan L, et al
    Gomisin A and metformin co-treatment attenuates diabetic nephropathy and cardiovascular dysfunction by modulating the AGE/RAGE pathway in a diabetic rat model.
    Mol Cell Biochem. 2026 Feb 14. doi: 10.1007/s11010-026-05497.
    

    >> Share

    
    

    
    N Engl J Med

80. LIP GYH, Kuzma L
    Thromboprophylaxis for Atrial Fibrillation in Patients with Drug-Eluting Stents.
    N Engl J Med. 2026;394:713-715.
    

    >> Share

    
    

    
    Thromb Haemost

81. MROZ K, Paszek E, Wypasek E, Undas A, et al
    Inherited Thrombophilia as a Risk Factor for Persistent Left Ventricular Thrombus Following Acute Myocardial Infarction.
    Thromb Haemost. 2026 Feb 9. doi: 10.1055/a-2794-5001.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share